{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:58:24Z","timestamp":1771300704445,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Prince of Songkhla University (PSU), Reinventing University Project","award":["Grant Number 175623"],"award-info":[{"award-number":["Grant Number 175623"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00727-9","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:51:53Z","timestamp":1768319513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of antidiabetic leads using in-silico screening, molecular dynamics simulation, and biological evaluation using cell viability, anti-adipogenesis, glucose uptake, and peroxisome proliferator activated receptor-\u03b3 in-vitro assay"],"prefix":"10.1007","volume":"40","author":[{"given":"Virendra","family":"Nath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Prem","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titpawan","family":"Nakpheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanyanat","family":"Kaewiad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juthanat","family":"Kaeobamrung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerapol","family":"Srichana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4093\/dmj.2024.0818","volume":"49","author":"SE Park","year":"2025","unstructured":"Park SE, Ko SH, Kim JY et al (2025) Diabetes fact sheets in Korea 2024. Diabetes Metab J 49:24\u201333. https:\/\/doi.org\/10.4093\/dmj.2024.0818","journal-title":"Diabetes Metab J"},{"key":"727_CR2","doi-asserted-by":"publisher","unstructured":"Ahmed MM, Ibrahim RM, Younis NM (2025) Diabetic distress among patients with type II: a descriptive study. Adv Biomed Res 14. https:\/\/doi.org\/10.4103\/abr.abr_328_24","DOI":"10.4103\/abr.abr_328_24"},{"key":"727_CR3","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.124.001074","author":"S Allamreddy","year":"2024","unstructured":"Allamreddy S, Arora M, Ganugula R et al (2024) Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: challenges, risks, and strategies. Pharmacol Rev. https:\/\/doi.org\/10.1124\/pharmrev.124.001074","journal-title":"Pharmacol Rev"},{"key":"727_CR4","doi-asserted-by":"publisher","unstructured":"Yapislar H, Gurler EB (2024) Management of microcomplications of diabetes mellitus: challenges, current trends, and future perspectives in treatment. Biomedicines 12:1958. https:\/\/doi.org\/10.3390\/biomedicines12091958","DOI":"10.3390\/biomedicines12091958"},{"key":"727_CR5","doi-asserted-by":"publisher","DOI":"10.4172\/2167-065X.1000117","author":"N Tiwari","year":"2014","unstructured":"Tiwari N (2014) Therapeutic targets for diabetes mellitus: an update. Clin Pharmacol Biopharm. https:\/\/doi.org\/10.4172\/2167-065X.1000117. 3:","journal-title":"Clin Pharmacol Biopharm"},{"key":"727_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/25931","volume":"395","author":"RT Nolte","year":"1998","unstructured":"Nolte RT, Wisely GB, Westin S et al (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-\u03b3. Nature 395:137\u2013143. https:\/\/doi.org\/10.1038\/25931","journal-title":"Nature"},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.drudis.2010.05.015","volume":"15","author":"S P\u00e9rot","year":"2010","unstructured":"P\u00e9rot S, Sperandio O, Miteva MA et al (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 15:656\u2013667","journal-title":"Drug Discov Today"},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0014-827X(02)01211-9","volume":"57","author":"C Sotriffer","year":"2002","unstructured":"Sotriffer C, Klebe G (2002) Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design. Il Farmaco 57:243\u2013251. https:\/\/doi.org\/10.1016\/S0014-827X(02)01211-9","journal-title":"Il Farmaco"},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0969-2126(01)00634-7","volume":"9","author":"P Cronet","year":"2001","unstructured":"Cronet P, Petersen JFW, Folmer R et al (2001) Structure of the PPAR\u03b1 and -\u03b3 ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9:699\u2013706. https:\/\/doi.org\/10.1016\/S0969-2126(01)00634-7","journal-title":"Structure"},{"key":"727_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"R Kapadia","year":"2008","unstructured":"Kapadia R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13:1813. https:\/\/doi.org\/10.2741\/2802","journal-title":"Front Biosci"},{"key":"727_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neuropharm.2016.06.009","volume":"109","author":"GJ Song","year":"2016","unstructured":"Song GJ, Nam Y, Jo M et al (2016) A novel small-molecule agonist of PPAR-\u03b3 potentiates an anti-inflammatory M2 glial phenotype. Neuropharmacology 109:159\u2013169. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.009","journal-title":"Neuropharmacology"},{"key":"727_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/10600280241262513","author":"AA Alfadda","year":"2024","unstructured":"Alfadda AA, Youssef AM, Al-Sofiani ME et al (2024) Medication adherence and treatment satisfaction with lipid-lowering drugs among patients with diabetes and dyslipidemia. Ann Pharmacother. https:\/\/doi.org\/10.1177\/10600280241262513","journal-title":"Ann Pharmacother"},{"key":"727_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2174\/1573409915666191018121558","volume":"16","author":"MA Khedr","year":"2021","unstructured":"Khedr MA, Mohafez OMM, Al-Haider IA (2021) Virtual screening-based discovery of potent hypoglycemic agents: in silico, chemical synthesis and biological study. Curr Comput Aided Drug Des 16:741\u2013756. https:\/\/doi.org\/10.2174\/1573409915666191018121558","journal-title":"Curr Comput Aided Drug Des"},{"key":"727_CR14","unstructured":"Sreelatha K, Sanobar SA, Sruthi K, Sumakanth M (2020) Structure based virtual Screening, design, synthesis and biological evaluation of Imidazoles as anti-diabetic agents. J Pharmaceuti Sci Res 12(12):1515\u20131526."},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.bmcl.2008.05.056","volume":"18","author":"H Park","year":"2008","unstructured":"Park H, Hwang KY, Kim YH et al (2008) Discovery and biological evaluation of novel \u03b1-glucosidase inhibitors with in vivo antidiabetic effect. Bioorg Med Chem Lett 18:3711\u20133715. https:\/\/doi.org\/10.1016\/j.bmcl.2008.05.056","journal-title":"Bioorg Med Chem Lett"},{"key":"727_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"727_CR17","doi-asserted-by":"publisher","unstructured":"Mazumder M, Ponnan P, Das U et al (2017) Investigations on binding pattern of kinase inhibitors with PPAR \u03b3: molecular docking, molecular dynamic simulations, and free energy calculation studies. PPAR Res 2017. https:\/\/doi.org\/10.1155\/2017\/6397836","DOI":"10.1155\/2017\/6397836"},{"key":"727_CR18","doi-asserted-by":"publisher","unstructured":"Muralikumar S, Vetrivel U, Narayanasamy A, Das UN (2017) Probing the intermolecular interactions of PPAR\u03b3-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties. Lipids Health Dis 16. https:\/\/doi.org\/10.1186\/s12944-016-0404-3","DOI":"10.1186\/s12944-016-0404-3"},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10822-009-9281-4","volume":"23","author":"S Kawatkar","year":"2009","unstructured":"Kawatkar S, Wang H, Czerminski R, Joseph-McCarthy D (2009) Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using glide. J Comput Aided Mol Des 23:527\u2013539. https:\/\/doi.org\/10.1007\/s10822-009-9281-4","journal-title":"J Comput Aided Mol Des"},{"key":"727_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/07391102.2019.1581089","volume":"38","author":"V Nath","year":"2020","unstructured":"Nath V, Agrawal R, Kumar V (2020) Structure based docking and molecular dynamics studies: peroxisome proliferator-activated receptors\u2014\u03b1\/\u03b3 dual agonists for treatment of metabolic disorders. J Biomol Struct Dyn 38:511\u2013523. https:\/\/doi.org\/10.1080\/07391102.2019.1581089","journal-title":"J Biomol Struct Dyn"},{"key":"727_CR21","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1080\/07391102.2023.2214223","volume":"42","author":"A Bhatnagar","year":"2024","unstructured":"Bhatnagar A, Nath V, Kumar N, Kumar V (2024) Discovery of novel PARP-1 inhibitors using tandem in silico studies: integrated docking, e-pharmacophore, deep learning based de Novo and molecular dynamics simulation approach. J Biomol Struct Dyn 42:3396\u20133409. https:\/\/doi.org\/10.1080\/07391102.2023.2214223","journal-title":"J Biomol Struct Dyn"},{"key":"727_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52:W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1055\/a-2107-5653","volume":"34","author":"W Kaewman","year":"2023","unstructured":"Kaewman W, Kaeobamrung J (2023) DMAP-catalyzed domino reactions of \u03b1-chloroaldoxime O-methanesulfonates and 2-aminobenzoic acids for the synthesis of Quinazolinediones. Synlett 34:2052\u20132058. https:\/\/doi.org\/10.1055\/a-2107-5653","journal-title":"Synlett"},{"key":"727_CR25","doi-asserted-by":"publisher","unstructured":"Kim NY, Lim CM, Park HM et al (2022) MMPP promotes adipogenesis and glucose uptake via binding to the PPAR\u03b3 ligand binding domain in 3T3-L1 MBX cells. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.994584","DOI":"10.3389\/fphar.2022.994584"},{"key":"727_CR26","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1210\/en.2011-0225","volume":"152","author":"O Dubuisson","year":"2011","unstructured":"Dubuisson O, Dhurandhar EJ, Krishnapuram R et al (2011) PPAR\u03b3-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology 152:3648\u20133660. https:\/\/doi.org\/10.1210\/en.2011-0225","journal-title":"Endocrinology"},{"key":"727_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0131-0","author":"YM Cho","year":"2018","unstructured":"Cho YM, Kim DH, Lee KH et al (2018) The IRE1\u03b1-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPAR\u03b3 activity. Exp Mol Med. https:\/\/doi.org\/10.1038\/s12276-018-0131-0. 50:","journal-title":"Exp Mol Med"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00727-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:57:28Z","timestamp":1768366648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00727-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00727-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest. They also have no known competing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"48"}}